Glioblastoma, is the most frequent malignant tumor of the Central Nervous System and, due to its heterogeneity and its high capacity for local invasion, in most cases it has a poor prognosis, despite current treatment protocols. One of the characteristics of the glioblastoma microenvironment is hypoxia, generated by rapid tumor growth. The invasive capacity of […]
Researchers from the Neurodegenerative Diseases Group of IDIVAL have participated in the first study of genomic association (GWAs) in Parkinson's disease carried out in Spain. This is a study that has had the participation of 13 Spanish centers and has included 7,849 subjects with Parkinson's disease and healthy controls. The study has served to characterize […]
The central role of Mesenchymal Stem Cells (MSC) in Regenerative Medicine derives, in large part, from their ability to differentiate into different cell types. The induction of proliferation and differentiation to osteoblasts of MSCs forms the basis of bone regenerative therapies. Osteogenic differentiation of MSCs is a complex process regulated simultaneously by different signaling routes, […]
Recently, after the evaluation by international experts carried out by the Carlos III Health Institute, the 7th Call for Research Projects on HIV, Liver Diseases and Hemato-oncology of GILEAD Sciences has been resolved in which the “Liquid biopsy for the molecular diagnosis of DLBCL patients treated in clinical trials (GLD19 / 00041)” research project lead by […]
The candidacy of BIOBANCO VALDECILLA, has been selected for the organization of the XI CONGRESS OF THE NATIONAL BIOBANK NETWORK – SANTANDER 2020 From now on the countdown begins with the clear objective of making it a success both for your organization, as for its contents, speakers and participants. The Congress that will be held in […]
Dr. Federico Castillo Suescun, has patented with the help of IDIVAL two devices whose use can contribute to improve the prognosis of patients with an open abdomen, a very serious medical condition, with a mortality rate of 70%. His project is now in search of financing for its development with an improved design and the […]
The European Regions Research nd Innovation Network (ERRIN) recently hosted the first face-to-face meeting of the community of 10 mirror regions interested in implementing the inDemand co-creation model to design digital health solutions with local stakeholders. The project’s three pilot regions, Murcia (Spain), Oulu (Finland) and Paris (France) have all seen […]
Dr. David San Segundo, immunologist of the HUMV Immunology Service and researcher of the IDIVAL Transplant and Autoimmunity group, has been chosen to be part of the ESOT (European Organ Transplantation Society) Basic Science Committee during the congress held in September in Copenhagen. The Committee is made up of 7 members, with a balanced composition […]
The Cognitive Impairment Unit of the Marqués de Valdecilla University Hospital has developed a new and original test for the differential diagnosis of dementias. The study, which has been published in the Journal of Alzheimer's Disease, shows how by carrying out four drawings (turtle, strawberry, envelope and train) the researchers were able to diagnose with […]
The Cardiovascular Research group led by Dr. De La Torre has obtained funding from the Carlos III Health Institute in the last call of the recently resolved National Plan. Coronary heart disease and its consequences are leaders in morbidity and mortality and resource consumption in developed countries like ours. Population aging and longer life expectancy […]
